Cosmetic Procedures: An Overview of Evidence-Based Approaches

Cosmetic procedures have moved from a niche specialty to one of the most rapidly expanding areas of clinical dermatology and plastic surgery.

The International Society of Aesthetic Plastic Surgery reported approximately 34.9 million aesthetic treatments worldwide in 2023.

This article provides a practical overview of the most commonly performed non-surgical cosmetic procedures, the evidence supporting their use, and the key safety considerations described in the clinical literature.

Three Major Categories

The majority of non-surgical cosmetic procedures fall into three broad categories.

• Neuromodulators — primarily botulinum toxin type A, used for dynamic wrinkle reduction
• Soft tissue fillers — including hyaluronic acid, calcium hydroxylapatite, and poly-L-lactic acid
• Energy-based devices — lasers, intense pulsed light, radiofrequency, and ultrasound systems

Each category targets different aspects of facial aging or skin appearance, and they are increasingly used in combination rather than in isolation.

Botulinum Toxin

Botulinum toxin type A is the most frequently performed non-surgical cosmetic procedure worldwide. Its primary mechanism is the temporary blockade of acetylcholine release at the neuromuscular junction, which reduces the dynamic muscle activity that produces certain facial lines.

The published evidence base is large and consistent regarding efficacy for glabellar lines, lateral canthal lines (often called crow's feet), and forehead lines.

The duration of effect typically falls in the range of three to four months for most facial indications, although individual response varies based on dose, injection technique, and the specific muscle treated.

Reported adverse events are generally mild and transient. The most commonly cited include localized bruising, headache, and asymmetric outcomes when injection placement is suboptimal. Serious adverse events such as ptosis and brow asymmetry are documented but uncommon in experienced hands.

Soft Tissue Fillers

Soft tissue fillers address volume loss and structural changes that neuromodulators do not affect. The most widely used materials are hyaluronic acid-based products, which offer the practical advantage of being reversible through hyaluronidase administration.

Other materials, such as calcium hydroxylapatite and poly-L-lactic acid, function partly as biostimulators, prompting endogenous collagen production over a longer time frame.

Reviews of complication rates indicate that adverse events are relatively rare overall, but the spectrum of possible complications is broader than with neuromodulators.

Reported adverse events include nodules, erythema, vascular occlusion, and infection. The Global Aesthetics Consensus emphasizes that prevention depends heavily on detailed anatomic knowledge, conservative injection volumes, and recognition of high-risk facial regions, particularly around the glabella and nasolabial area.

Energy-Based Devices

Energy-based devices cover a heterogeneous group of technologies, including ablative and non-ablative lasers, fractional resurfacing systems, intense pulsed light, radiofrequency devices, and high-intensity focused ultrasound.

These modalities are used for indications such as photoaging, pigmentary irregularities, vascular lesions, and skin laxity.

The literature in this area is more heterogeneous than for injectables. Outcomes depend strongly on device parameters, treatment protocols, and skin phototype, which makes direct comparisons across studies difficult.

Adverse event profiles also vary by modality. Ablative laser resurfacing carries a higher risk of post-inflammatory hyperpigmentation, particularly in patients with Fitzpatrick skin types IV through VI, and selection of appropriate parameters for darker skin remains an active area of clinical research.

Combination Approaches

Contemporary aesthetic practice frequently combines these categories rather than relying on a single intervention.

A systematic review of combination protocols found that biostimulator-based fillers combined with botulinum toxin, energy-based devices, or microneedling produced notable improvements in skin texture, elasticity, and contour, particularly in areas showing signs of aging.

The same review noted adverse events including erythema, bruising, and nodules in 15 to 30 percent of cases, with rare but serious complications such as granulomas and vascular occlusions.

The practical implication is that combination protocols can offer additive benefits, but they also require more careful patient selection, treatment planning, and post-procedure monitoring.

Patient-Reported Outcomes

One trend in the recent literature is the increased use of patient-reported outcome (PRO) instruments to evaluate the success of cosmetic interventions.

Unlike objective clinical scales, PROs capture dimensions such as satisfaction with appearance, psychosocial wellbeing, and confidence in social settings.

The U.S. Food and Drug Administration now often requires PRO data for new pharmaceutical approvals, and validated PRO instruments have become standard in aesthetic research.

This shift reflects a broader recognition that the goals of cosmetic procedures are not purely physical and that meaningful evaluation requires both clinical and subjective measures.

Practical Considerations

For readers reviewing the literature in this area, several points are worth keeping in mind.

First, the evidence base varies significantly across procedure types. Botulinum toxin has the most robust supporting literature; novel device technologies often have far less peer-reviewed evidence at the time of market introduction.

Second, individual outcomes depend on factors that are difficult to capture in clinical trials, including injector experience, patient anatomy, and baseline skin characteristics.

Third, ethnic and regional differences in skin biology, facial structure, and aesthetic preferences are increasingly recognized as important variables. Much of the foundational research was conducted in predominantly Caucasian populations, and the relevance of those findings to other populations is an active area of investigation.

Summary

Non-surgical cosmetic procedures form a large and evolving area of clinical practice. The three major categories — neuromodulators, soft tissue fillers, and energy-based devices — have distinct mechanisms, evidence bases, and safety profiles, and they are increasingly used in combination.

For both practitioners and informed readers, a clear understanding of these categories and the supporting evidence is the foundation for evaluating any specific procedure or claim.

Primary literature on the topics discussed in this article is available through PubMed. A comprehensive consensus statement on botulinum toxin use is available through the Global Aesthetics Consensus published in PMC.